OS5.1 Sequence of bevacizumab and lomustine in patients with first progression of a glioblastoma: phase II EORTC study 26101
OS5.1 贝伐单抗和洛莫司汀序贯治疗胶质母细胞瘤首次进展患者：EORTC 26101 II期研究
期刊:Biophysical Journal
影响因子:3.1
doi:10.1016/S0006-3495(88)83069-8
Koenig, S H; Sweis, Nadia; Velis, Yesenia; Perez, Julienne Sanchez; Senft, Nicole; Sanderson, Maureen; Selove, Rebecca; Blot, William J; Tyndale, Rachel F; Cai, Quiyin; Gilliam, Karen; Kundu, Suman; Tindle, Hilary A; Seneviratne Epa, Dilan; Ng, Elisabeth; Nagalingam, Vathy; Schneider, Hans; Bach, Leon; Sztal-Mazer, Shoshana; Wick, W; Stupp, R; Gorlia, T; Bendszus, M; Brandes, A A; Voss, M J; Le Rhun, E; Clement, P M; Golfinopoulos, V; van den Bent, M
